• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Avax Technologies Inc

+ Add to Watchlist


0.0126 USD 0.00000.00%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Avax Technologies Inc (AVXT)

Open: 0.0125 Day's Range: 0.0125 - 0.0133 Volume: 410,000
Previous Close: 0.0126 52wk Range: 0.0018 - 0.0500 1-Yr Rtn: +40.00%

Stock Chart for AVXT

No chart data available.
  • AVXT:US 0.0126
  • 1D
  • 1M
  • 1Y
Interactive AVXT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AVXT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0400
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 1.80
Shares Outstanding (M) 142.61
30 Day Average Volume 461,623
Price/Book (mrq) -
Price/Sale (ttm) 2.4365
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AVXT

No data available

Company Profile & Key Executives for AVXT

AVAX Technologies, Inc. develops and commercializes individualized therapies and other novel technologies primarily focused on cancer and other life-threatening diseases. The Company's lead development program is the AC Vaccine, which attempts to stimulate the patient's own immune system to recognize, contain, and eliminate cancer cells.

John K A PrendergastChairman/CEOFrancois MarteletPresident/Investor Relations
Howard S FischerChief Financial OfficerDavid BerdChief Medical Officer
More Company Profile & Key Executives for AVXT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil